CMALX
Price
$26.91
Change
+$0.05 (+0.19%)
Updated
Jan 17 closing price
Net Assets
147.73M
VBAIX
Price
$49.15
Change
+$0.28 (+0.57%)
Updated
Jan 17 closing price
Net Assets
57.48B
Ad is loading...

CMALX vs VBAIX

Header iconCMALX vs VBAIX Comparison
Open Charts CMALX vs VBAIXBanner chart's image
Crawford Multi-Asset Income
Price$26.91
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets147.73M
Vanguard Balanced Index I
Price$49.15
Change+$0.28 (+0.57%)
VolumeN/A
Net Assets57.48B
CMALX vs VBAIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMALX vs. VBAIX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMALX is a Buy and VBAIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VBAIX has more cash in the bank: 57.5B vs. CMALX (148M). CMALX pays higher dividends than VBAIX: CMALX (4.57) vs VBAIX (1.99). CMALX was incepted earlier than VBAIX: CMALX (7 years) vs VBAIX (24 years). CMALX is a more actively managed with annual turnover of: 35.00 vs. VBAIX (19.00). CMALX has a lower initial minimum investment than VBAIX: CMALX (10000) vs VBAIX (5000000). CMALX annual gain was more profitable for investors over the last year : 13.97 vs. VBAIX (12.42). VBAIX return over 5 years is better than : 28.98 vs. CMALX (25.81).
CMALXVBAIXCMALX / VBAIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years24 years-
Gain YTD1.8931.361139%
Front LoadN/AN/A-
Min. Initial Investment1000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets148M57.5B0%
Annual Yield % from dividends4.571.99230%
Returns for 1 year13.9712.42113%
Returns for 3 years15.387.77198%
Returns for 5 years25.8128.9889%
Returns for 10 yearsN/A84.42-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCTI0.960.11
+12.63%
Healthcare Triangle
MPTI55.421.91
+3.57%
M-tron Industries
FOLD9.410.05
+0.53%
Amicus Therapeutics
TMP66.950.31
+0.47%
Tompkins Financial Corp
RPRX30.75-0.20
-0.65%
Royalty Pharma plc